Rationale for targeting complement in COVID‐19
Abstract A novel coronavirus, SARS‐CoV‐2, has recently emerged in China and spread internationally, posing a health emergency to the global community. COVID‐19 caused by SARS‐CoV‐2 is associated with an acute respiratory illness that varies from mild to the life‐threatening acute respiratory distres...
Saved in:
| Main Authors: | Anastasia Polycarpou, Mark Howard, Conrad A Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, Linda S Klavinskis, Steven Sacks |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-07-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202012642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Community series in the role of complement in health and disease, volume II
by: Maciej Cedzyński, et al.
Published: (2025-07-01) -
Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies
by: Yang Yang, et al.
Published: (2025-01-01) -
Complement levels and their diagnostic utility in neonatal sepsis
by: Fuqiang Diao, et al.
Published: (2025-05-01) -
Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy
by: Gabriel Ștefan, et al.
Published: (2024-02-01) -
The future of complement therapeutics
by: Martin Kolev, et al.
Published: (2024-10-01)